Topics Contents of page 2025 2024 2025 Aug. 8 : Consolidated Financial Summary (1Q/Apr-Jun FY2025) Aug. 8 : Notice regarding Cancellation of Treasury Shares[PDF 0.09MB] May 8 : Notice of Changes in Executive Officers[PDF 0.11MB] May 8 : Notice Concerning Dividends from Surplus (Increase)[PDF 0.17MB] 2024 June 19, 2024 : Zeria Pharmaceutical and Agastra-Lab announces reaching Agreement for the Development and Market Access of Acotiamide as a Functional Dyspepsia Treatment in Europe, the United States, and Canada[PDF 0.14MB]
